United Therapeutics Corp (NASDAQ:UTHR)

118.04
Delayed Data
As of 4:00pm ET
 +0.49 / +0.42%
Today’s Change
112.01
Today|||52-Week Range
153.58
-20.22%
Year-to-Date

Today’s Trading

Previous close117.55
Today’s open118.82
Day’s range115.71 - 119.20
Volume411,852
Average volume (3 months)424,108
Market cap$5.1B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-16.45%
Earnings growth (next 5 years)-8.45%
Revenue growth (last year)+9.08%
P/E ratio10.4
Price/Sales4.20
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.35+1.05%
GRFSGrifols SA+0.30+1.34%
CTLTCatalent Inc+0.42+0.99%
----
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateApril 25, 2018
EPS forecast (this quarter)$4.00
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts